Amir Golan

Company: Novartis

Job title: Vice President - Radioligand Therapy Platform

Seminars:

Panel Discussion: Reflecting on the Past Year- Discussing Current Radiopharmaceutical Trends & Assessing Our Progress 8:30 am

Exploring PSMA updates and predictions for the future market of prostate cancer drugs Pricing and reimbursement considerations in a competitive market Discussing key future commercial challenges and opportunities for the field from advances in manufacturing to competitive demand and selection of radioisotopes, with emphasis on actinium-225, lead-212, copper-64Read more

day: Conference Day One